Next Article in Journal
Silver Nanoparticles Formulation of Flower Head’s Polyphenols of Cynara scolymus L.: A Promising Candidate against Prostate (PC-3) Cancer Cell Line through Apoptosis Activation
Next Article in Special Issue
The Potential of Corchorus olitorius Seeds Buccal Films for Treatment of Recurrent Minor Aphthous Ulcerations in Human Volunteers
Previous Article in Journal
Effects of Ultra-High Pressure on Endogenous Enzyme Activities, Protein Properties, and Quality Characteristics of Shrimp (Litopenaeus vannamei) during Iced Storage
Previous Article in Special Issue
Cinnamaldehyde-Based Self-Nanoemulsion (CA-SNEDDS) Accelerates Wound Healing and Exerts Antimicrobial, Antioxidant, and Anti-Inflammatory Effects in Rats’ Skin Burn Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 19
10.3390/molecules27196306
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity

by
Saeed Ali Alsareii
1,
Abdulrahman Manaa Alamri
1,
Mansour Yousef AlAsmari
1,
Mohammed A. Bawahab
2,
Mater H. Mahnashi
3,*,
Ibrahim Ahmed Shaikh
4,
Arun K. Shettar
5,
Joy H. Hoskeri
6 and
Vijay Kumbar
7
1
Department of Surgery, College of Medicine, Najran University, Najran 61441, Saudi Arabia
2
Department of Surgery, Faculty of Medicine, King Khalid University, Abha 62529, Saudi Arabia
3
Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia
4
Department of Pharmacology, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia
5
Division of Preclinical Research and Drug Development, Cytxon Biosolutions Pvt Ltd., Hubli-580031, Karnataka, India
6
Department of Bioinformatics and Biotechnology, Karnataka State Akkamahadevi Women’s University, Vijayapura 586108, Karnataka, India
7
Maratha Mandal’s Dental College and Central Research Laboratory, Belgaum 590019, Karnataka, India
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(19), 6306; https://doi.org/10.3390/molecules27196306
Submission received: 20 August 2022 / Revised: 17 September 2022 / Accepted: 19 September 2022 / Published: 24 September 2022
(This article belongs to the Special Issue Novel Natural Compounds as Wound Healing Agents)
Browse Figures
Versions Notes

Abstract

:
Silver nanoparticles (AgNPs) have recently gained interest in the medical field because of their biological features. The present study aimed at screening Rhizophora apiculata secondary metabolites, quantifying their flavonoids and total phenolics content, green synthesis and characterization of R. apiculata silver nanoparticles. In addition, an assessment of in vitro cytotoxic, antioxidant, anti-inflammatory and wound healing activity of R. apiculata and its synthesized AgNPs was carried out. The powdered plant material (leaves) was subjected to Soxhlet extraction to obtain R. apiculata aqueous extract. The R. apiculata extract was used as a reducing agent in synthesizing AgNPs from silver nitrate. The synthesized AgNPs were characterized by UV-Vis, SEM-EDX, XRD, FTIR, particle size analyzer and zeta potential. Further aqueous leaf extract of R. apiculata and AgNPs was subjected for in vitro antioxidant, anti-inflammatory, wound healing and cytotoxic activity against A375 (Skin cancer), A549 (Lung cancer), and KB-3-1 (Oral cancer) cell lines. All experiments were repeated three times (n = 3), and the results were given as the mean ± SEM. The flavonoids and total phenolics content in R. apiculata extract were 44.18 ± 0.086 mg/g of quercetin and 53.24 ± 0.028 mg/g of gallic acid, respectively. SEM analysis revealed R. apiculata AgNPs with diameters ranging from 35 to 100 nm. XRD confirmed that the synthesized silver nanoparticles were crystalline in nature. The cytotoxicity cell viability assay revealed that the AgNPs were less toxic (IC50 105.5 µg/mL) compared to the R. apiculata extract (IC50 47.47 µg/mL) against the non-cancerous fibroblast L929 cell line. Antioxidant, anti-inflammatory, and cytotoxicity tests revealed that AgNPs had significantly more activity than the plant extract. The AgNPs inhibited protein denaturation by a mean percentage of 71.65%, which was equivalent to the standard anti-inflammatory medication diclofenac (94.24%). The AgNPs showed considerable cytotoxic effect, and the percentage of cell viability against skin cancer, lung cancer, and oral cancer cell lines was 31.84%, 56.09% and 22.59%, respectively. R. apiculata AgNPs demonstrated stronger cell migration and percentage of wound closure (82.79%) compared to the plant extract (75.23%). The overall results revealed that R. apiculata AgNPs exhibited potential antioxidant, anti-inflammatory, wound healing, and cytotoxic properties. In future, R. apiculata should be further explored to unmask its therapeutic potential and the mechanistic pathways of AgNPs should be studied in detail in in vivo animal models.

1. Introduction

The biosynthesis of AgNPs utilizing valuable medicinal plant extracts has expanded significantly due to the growing interest in studies of the nano-range of 1–100 nm for biomedical applications [1,2]. However, one of the essential components of modern nanotechnological techniques is the production of nanoparticles with an appropriate quality [1].
A vast array of the literature has described various strategies for metal nanoparticle synthesis involving chemical, electrochemical, photochemical, and other methods of reduction [3,4,5]. On the other hand, biological approaches have been claimed to be superior to chemical methods in terms of their economic feasibility and environmental safety. Micro-organisms’ biosynthesis of AgNPs is a well-established technique [6]. However, using plant-based materials rather than microbes for the green synthesis of metal nanoparticles has garnered much interest because of the lower toxicity, shorter processing time and the added benefit of natural capping agents. Furthermore, it lowers the cost of isolating microorganisms and improving culture conditions for microbe-assisted biosynthesis, and it employs a variety of reductant sources, including leaves, flowers and catkins [7].
AgNPs are primarily employed in antibacterial and anticancer treatments, but they are also used as biosensors, vaccine adjuvants, anti-diabetic agents, and in promoting bone and wound healing. High stability, high carrier capacity, the ability to incorporate both hydrophilic and hydrophobic molecules, and the ability to administer drugs via a variety of routes, including via oral application and inhalation, are key technological benefits of nanoparticles used as drug carriers. Excellent electrical conductivity, chemical stability, catalytic and antibacterial characteristics, as well as cytotoxic effects on cancer cells have all been demonstrated in silver nanoparticles.
At low concentrations, AgNPs have been shown to exhibit antibacterial, anti-biofilm and antiviral activities. Infection control is vital in medicine and various other industries, and a chemical-free option has become the need of the hour. Disinfection has become a vital parameter for pandemics such as COVID-19, and colloidal silver can be utilized as a novel standard for the preventative treatment of ventilator-acquired pneumonia in intensive care units of hospitals. Silver nanoparticles are effective antibacterial agents when used alone or in conjunction with existing medicines. After bioreduction by biosynthesized AgNPs, pharmaceutically important compounds can be preserved, which could have therapeutic implications. Because of their antibacterial properties, silver nanoparticles are commonly employed in the packaging industry to extend the shelf-life of food products [8,9,10].
Cancer is among the most significant causes of mortality around the globe, accounting for over 10 million deaths in 2020, or roughly one in every six. Cancers of the breast, lungs, gastrointestinal tract (including the cervix), and prostate are among the most prevalent. The five-year survival rate for oral, lung, and skin cancer (melanoma) is 55%, 26%, and 68%, respectively. The success rate of chemotherapy is not very encouraging, and many patients also experience severe side effects. Therefore, there is a pressing need to continue researching useful diagnostic and cutting-edge therapy targets of natural origin. Due to its lower toxicity, researchers have recently focused on creating/discovering novel therapeutic compounds using natural resources.
Rhizophora apiculata is one such mangrove plant, which belongs to the Plantae kingdom under the Rhizophoraceae family. It is well-known for its medicinal properties [11]. R. apiculata has medicinal properties in its roots, bark, and leaves. These trees are high in phytochemicals and have anticancer, antibacterial, antiemetic, antidiarrheal, and hemostatic activity [12,13]. Previously, R. apiculata has been assessed for its antibacterial activity [14], hepatoprotective activity [15], and cytotoxic activity [16,17]. Throughout the prehistoric era, plants were used as a source of treatment for various diseases worldwide. Numerous undiscovered natural products and nutrients have biologically beneficial properties [18]. As a result, there is an urgent need to discover and test new treatment alternatives that can effectively be used in disease management while causing minimal side effects. Hence, we thought it worthwhile to carry out this research with the following objectives: (1) phytochemical screening and quantification of secondary metabolites from R. apiculata, (2) green synthesis and characterization of silver nanoparticles from R. apiculata, (3) determination of in vitro antioxidant and anti-inflammatory activity of R. apiculata and its synthesized AgNPs, (4) in vitro anticancer activity of aqueous leaf extract of R. apiculata and its synthesized AgNPs against skin cancer, lung cancer, and oral cancer, and (5) in vitro wound-healing activity of aqueous leaf extract of R. apiculata and its synthesized AgNPs by scratch assay.

2. Results

2.1. Phytochemical Analysis

The findings of the phytochemical study showed that significant bioactive components such as glycosides, saponins, terpenoids, flavonoids, and phenols were present in the test extract (Table 1). The aqueous leaf extract of R. apiculata exhibited a total of 44.18 ± 0.08 mg/g of quercetin-equivalent flavonoid content and 53.24 ± 0.02 mg/g of gallic-acid-equivalent phenolic content.

2.2. Visual Observation and UV-VIS Characterization

The addition of R. apiculata leaf aqueous extract to 1 mM AgNO3 solution caused a color shift from yellowish to brown after 4 h, indicating the bioreduction of AgNO3 from silver metal ions (Ag+) to silver nanoparticles (Ag0) (Figure 1). After 1 h, the reaction was complete with a brown color. Silver nanoparticles were confirmed by UV-VIS spectral spectroscopy of the colloidal solution at 200–1100 nm. The maximal absorption peak (max) was at 459 nm (Figure 2).

2.3. SEM and EDX Studies

SEM investigations validated the morphology and surface of the AgNPs. The SEM images revealed silver nanoparticles with an irregular form and a diameter between 35 and 100 nanometers. EDX experiments helped to determine the purity and composition of the AgNPs. The formation of AgNPs was confirmed by the high signal in the 3 Kev metallic silver region. Besides silver, other elements including carbon and oxygen were found to make up 30.71% and 61.41%, respectively, of its elemental composition analyses (Figure 3 and Figure 4).

2.4. FTIR Analysis

The functional groups responsible for the bioreduction of Ag+ into Ag0 nanoparticles were identified using FTIR spectroscopy. It was found that functional groups such as aromatic and aliphatic amines, alkyl halides, alkynes, alcohols, esters, carboxylic acids, ethers, and nitrogen compounds were present in the infrared spectra of the plant extracts as well as the AgNPs (Figure 5 and Figure 6). The FTIR analysis of the AgNPs showed major peaks at 3729.19 cm−1, 3434.14 cm−1, 2957.37 cm−1, 2860.83 cm−1, 1745.22 cm−1, 1635.04 cm−1, 1541.04 cm−1, 1458.00 cm−1, 1380.21 cm−1, 1265.41 cm−1, 1124.12 cm−1, 1039.87 cm−1, and 554.85 cm−1 corresponding to the presence of alcohol, amines, imines, alkanes, nitro-compounds, phenols, and alkyl halides as a major functional groups. These functional groups might have been acting as capping, stabilizing, and reducing agents in the synthesis of nanoparticles from the plant extract.

2.5. Particle Size Analyzer and Zeta Potential

Using a zeta potential analyzer with D.L.S., the average hydrodynamic size and dispersion of the AgNPs were analyzed. AgNPs with an average diameter of 99 nm, with a zeta potential of −6 mV, were found by the DLS analysis (Figure 7 and Figure 8).

XRD Analysis

The XRD analysis showed sharp peaks at different angles i.e., 23.5210, 27.7920, 32.1954, 33.2915, 37.6234, 38.0849, 38.5761, 44.1340, and 46.1686. These degrees of angles corresponded to the crystalline nature of the material. Hence, it was confirmed that the synthesized silver nanoparticles were crystalline (Figure 9).

2.6. In Vitro Antioxidant Activity

The in vitro antioxidant activity of the synthesized AgNPs and plant extract was estimated using FRAP, H2O2, DPPH, and PM assays.

2.6.1. FRAP Assay

The FRAP assay was used to test different concentrations of the R. apiculata aqueous leaf extract and its AgNPs, with ascorbic acid as a standard. The antioxidant activity and absorbance increased when the concentration of both standard and AgNPs rose. The AgNPs had higher antioxidant activity than the standard, with an absorbance of 1.81 ± 0.02, while the standard showed an absorbance of 1.46 ± 003. The absorbance of the plant extract was 0.86 ± 0.02 (Table 2).

2.6.2. H2O2 Assay

The hydrogen peroxide radical scavenging assay revealed that the AgNPs showed higher scavenging activity (74.98 ± 0.31% inhibition) than the standard (74.46 ± 0.13) and the plant extract showed a 63.58 ± 0.44% inhibition (Table 3).

2.6.3. DPPH Assay

The R. apiculata leaf extract and its AgNPs were tested against ascorbic acid to determine their antioxidant potential. The aqueous leaf extract was shown to have equivalent antioxidant activity to the AgNPs, while the standard ascorbic acid exhibited the highest activity (Table 4).

2.6.4. PM Assay

In this study, aqueous leaf extract of R. apiculata and its synthesized AgNPs were put through a PM assay along with the standard ascorbic acid. The AgNPs exhibited the highest antioxidant activity, followed by the aqueous plant extract and the standard ascorbic acid (Table 5).

2.6.5. In Vitro Anti-Inflammatory Assay

A protein denaturation assay was used to test the anti-inflammatory activity of a known concentration of the AgNPs and aqueous leaf extract of R. apiculata. The anti-inflammatory effect of the extracts was comparable to that of the standard drug Diclofenac sodium. There were significant differences (p ≤ 0.001) in protein denaturation between the groups. The results showed that the standard drug had the highest anti-inflammatory activity (94.24 ± 1.90%), followed by AgNPs (71.65 ± 0.88%) and the plant extract (54.34 ± 3.26%) (Table 6).

2.7. Cytotoxicity Activity of Aqueous Leaf Extract of R. Apiculata and Its Synthesized AgNPs against Non-Cancerous Fibroblast L929 Cell Line

The present cytotoxicity cell viability assay revealed that in both the tested samples, dose-dependent activity was observed. In comparison, the aqueous leaf extract of R. apiculata showed a larger decrease in the cell viability than the AgNP-treated cells. In the case of the plant extract, the percentage of cell viability was observed to be 46.81 ± 0.002%, whereas for the AgNPs, it was observed to be 77.50 ± 0.005 % (Table 7 and Figure 10).

2.8. Cytotoxic Activity of Aqueous Leaf Extract of R. apiculata and Its Synthesized AgNPs against A375 (Skin Cancer), A549 (Lung Cancer), and KB-3 (Oral Cancer)

The silver nanoparticles showed significant activity with a high percentage of cell death and a lower percentage of cell viability, i.e., for skin cancer (A375), the AgNPs showed 31.84 ± 0.004%, for lung cancer (A549) it was 56.09 ± 0.010%, and for oral cancer (KB-3) it was 22.59 ± 0.022%. On comparison within the tested group of cancer cell lines, the AgNPs showed a higher activity in oral cancer followed by skin cancer and lung cancer. In the case of the plant extract, the MTT cell viability results showed that, compared to the AgNPs, the extract showed moderate activity, i.e., for skin cancer (A375) 82.69 ± 0.002%, for lung cancer (A549) 73.73 ± 0.002%, and ovary cancer 67.17 ± 0.002% (Table 8 and Figure 11).

2.9. In Vitro Wound Healing Activity of Aqueous Leaf Extract of R. apiculata and Its Synthesized AgNPs

The cell migration results showed an increase in the cell migration in the standard and AgNPs- treated cells than the aqueous leaf extract of R. apiculata. In comparison, the standard drug ascorbic acid showed higher cell migration activity followed by the AgNPs, plant extract, and the untreated group. For the standard at 6 h, 12 h, and 24 h, the cell migration was found to be 25.47 µm, 28.03 µm, and 21.74 µm, respectively. Similarly, the AgNPs showed 14.43 µm, 20.56 µm, and 18.23 µm of cell migration at 6 h, 12 h, and 24 h, respectively. The aqueous leaf extract of R. apiculata showed 11.63 µm, 14.58 µm, and 18.74 µm. In the case of the wound closure study, 24 hrs of incubation was considered for the analysis and calculation. In comparison, the standard drug ascorbic acid showed a value of 96.26% of wound closure. In contrast, the AgNPs and aqueous leaf extract of R. apiculata showed 82.79% and 75.23%, respectively, and for the untreated group, it was found to be 9.13% (Table 9 and Table 10 and Figure 12).

3. Discussion

The “green” method for making nanoparticles, which is faster than traditional chemical synthesis, is fascinating because it is good for the environment, saves money, is practical, and can be used in many different ways. Biosynthesized nanoparticles are a relatively new field, and they can be used in many different ways, such as drug delivery, cancer therapy, gene treatment and DNA analysis, antibacterial agents, biosensors, increasing response rates, and so on. Nanoparticles are used in electrical engineering, medicine, biology, textiles, and chemistry. The shape and size of colloidal metal particles are significant in many applications, such as making magnetic and electronic devices, healing wounds, expressing antimicrobial genes, and making bio composites. Based on the size and shape of the particles, the optical and electromagnetic properties of noble metal colloids vary [19].
Unlike physical and chemical methods, the green eco-friendly synthesis of nanoparticles is biocompatible, cost-effective, takes less time and energy, and is non-toxic. Biological sources such as plant extracts, bacteria, fungi, and algae are used to make silver nanoparticles [20,21]. This study used a method called “phytoreduction” to make silver nanoparticles from the R. apiculata plant. In the process of turning silver into silver nanoparticles, the leaf extract from R. apiculata was used as a reducing and capping agent. Screening for phytochemicals showed a wide range of secondary metabolites, most of which were saponins, glycosides, terpenoids, phenols, flavonoids, and tannins. The high levels of phenols and flavonoids in the aqueous leaf extract of R. apiculata were also quantified. For the creation of silver nanoparticles, a concentrated aqueous leaf extract was added to a solution of silver nitrate, and the change in the color confirmed the formation of AgNPs. After 4 h, the solution turned a dark brown color. The surface and shape of the AgNPs were confirmed by SEM studies. The SEM analysis revealed R. apiculata AgNPs with diameters ranging from 35 to 100 nm. The EDX analysis gives a qualitative and quantitative status of the elements that may contribute to the formation of N.P.s. EDX spectroscopy was used for elemental analysis. Based on the analysis, Ag seemed to be the key ingredient. Due to surface plasmon resonance (SPR) [22], metallic AgNPs show a typical optical absorption peak around 3.00 keV. A strong signal of metallic silver nanoparticles at 3 Kev confirmed the formation of silver nanoparticles.
The FTIR spectra of the plant extract and AgNPs revealed the presence of functional groups such as alkyl halides, alkynes, aromatics and aliphatic amines, esters, ethers, alcohol, carboxylic acids, and nitro compounds, which may have acted as capping and reducing agents for the synthesis of the AgNPs. The FTIR findings were consistent with the findings of Rashid et al., 2021, who used FTIR analysis to determine the type of bonds and functional group in Au:ZnO (core:shell) nanoparticles via laser ablation nanoparticles prepared in deionized water [23].
The zeta potential method shows how the surface charge changes over time. This method is used to control the stability of metal nanoparticles in colloidal form. When the zeta potential of metal nanoparticles is either very positive or very negative, they tend to push away from each other and do not want to come together. However, when the absolute zeta potential is low, these particles stick together and clump together because no force keeps them from doing so. Using the dynamic light scattering measurement technique, the size of the silver nanoparticles was identified. Dynamic light scattering (DLS) is a way to measure the size of particles by pointing a laser beam on a suspension of particles or molecules moving in a Brownian motion. Size and zeta potential are important because they directly affect the particles stability, biodistribution, and uptake by cells [24,25]. In this study, a zeta potential analyzer with the DLS technique was used to figure out the average hydrodynamic size and size distribution of the green-made AgNPs. The DLS measurements showed that the AgNPs had an average diameter of 99 nm and a zeta potential of -6 mV. The amount of electrolyte and the pH of the dispersion have a big effect on the zeta potential of the particles. Due to negative repulsion, AgNPs have a good colloidal nature, stay stable over time, and spread out well when they have a high negative potential value [26].
Free radicals are chemical species with one or more electrons that are not paired with another electron. These are very unstable, and they take electrons from other molecules and damage them. These free radicals speed up the body’s abnormal, uncontrolled oxidation process. This causes the antioxidant defense system to fail and damages the cell structures, which increases the risk of Alzheimer’s, Parkinson’s, heart disease, liver disease, inflammation, and cancer, among other diseases. The risk of chronic disease and its progression can be reduced by boosting the body’s natural antioxidant defense or taking proven antioxidant supplements [27]. Antioxidant mechanisms in biological tissues are very complicated, and it is hard to judge the antioxidant power of crude extracts with just one method [28]. There are several in vitro testing methods for the antioxidant activity of pure compounds or extracts. So, in this study, four in vitro tests were used: the FRAP, PM, H2O2, and DPPH tests.
In the case of the FRAP assay, dose-dependent activity was observed. Among the tested groups, the silver nanoparticles showed the highest absorbance value, i.e., 1.81 ± 0.02 than standard ascorbic acid and aqueous leaf extract of R. apiculata. The standard drug ascorbic acid and the aqueous leaf extract showed 1.46 ± 0.003 and 0.86 ± 0.02, respectively.
The single concentration of silver nanoparticles, aqueous R. apiculata leaf extract, and standard ascorbic acid were tested for scavenging activity in a hydrogen peroxide assay. The AgNPs proved to be significant with the highest percentage of inhibition, i.e., 74.98 ± 0.31, whereas the standard ascorbic acid and aqueous leaf extract showed 74.46 ± 0.13 and 63.58 ± 0.44, respectively.
In the DPPH assay, the results were expressed in terms of the percentage of inhibition. The AgNPs and aqueous leaf extract were compared with the standard drug ascorbic acid. The results proved that the aqueous leaf extract showed higher activity than the AgNPs and standard ascorbic acid with 83.91 ± 0.3 percentage of inhibition, whereas the AgNPs and standard ascorbic acid showed 76.74 ± 0.7 and 77.36 ± 0.3 respectively.
In the case of the PM assay, the antioxidant activity was measured and expressed in the form of absorbance. The AgNPs showed higher absorbance, i.e., 1.447 ± 0.004, whereas the standard ascorbic acid showed 1.131 ± 0.007 and aqueous leaf extract showed 1.27 ± 0.004.
Inflammation plays a big part in many diseases, such as atherosclerosis, arthritis, asthma, heart disease, cancer, and other diseases [29]. Steroids and non-steroidal anti-inflammatory drugs are the main types of medicines used to treat inflammation. Their associated side effects (GI problems and leukopenia, for example) have made it necessary to discover other anti-inflammatory drugs that work the same way but do not have any adverse effects [30,31]. A protein denaturation assay was used to test the anti-inflammatory activity of known concentrations (100 g) of synthesized AgNPs and aqueous leaf extract of R. apiculata. In vitro, the anti-inflammatory effect of the extracts was comparable to that of the standard drug, Diclofenac sodium.
The levels of cell viability and rates of cell growth are good ways to judge if a cell is healthy. Cell health and metabolism can be changed by physical and chemical things. These agents can be toxic to cells in different ways, such as by destroying cell membranes, stopping protein synthesis, binding irreversibly to receptors, stopping polydeoxynucleotide elongation, and stopping enzymes from carrying out their jobs [32]. In vitro cell viability and cytotoxicity assays are often conducted with cultured cells to test chemical safety and find new drugs. In recent years, there has been more interest in how these tests can be used. At the moment, these assays are also used in oncology research to test both the toxicity of a compound and its ability to stop tumor cells from growing. Because they are quick, cheap, and don’t need to use animals, their applications are growing in the research area.
In the present study, a toxicity assay was studied by using an in vitro MTT cell viability assay against a non-cancerous fibroblast L929 cell line. The cytotoxicity cell viability assay revealed that, in both tested samples, a dose-dependent activity was observed. On comparison, the aqueous leaf extract of R. apiculata showed a larger decrease in cell viability as compared to the AgNP-treated cells. In the case of the plant extract, the percentage of cell viability was observed to be 46.81 ± 0.002, whereas for the AgNPs it was observed to be 77.50 ± 0.005. The results from the present study corroborate with those of previously reported studies. For example, Wen et al., 2020, reported that R. apiculata silver nanoparticles had strong cytotoxic effects on human osteosarcoma MG-63 cells, which could be attributable to the silver nanoparticles’ antioxidant activity [16]. Similarly, Daphne et al., 2018, reported that AgNPs synthesized by potent yeast isolates demonstrated positive antioxidant and antibacterial action, with AgNPs being bacteriostatic at low concentrations (5 ug/mL) and bactericidal at high concentrations (100 ug/mL) [21].
AgNPs are superior to other bulk materials because they have a good structure, are stable, and have a larger surface area [33]. Physical and chemical routes of synthesis are hazardous compared to biological methods [34]. Recently, physical, chemical, radiation therapy, chemotherapy, and surgical treatments are not working as well as they used to for the management of cancer. A big reason why drugs do not work is that cancer cells become resistant to them [35]. The discovery and development of new drugs to stop the growth of cancer cells is challenging because of their side effects, toxicity, and high cost [36].
Most people with light skin develop skin cancer. In many developed countries, skin cancer cases have increased in the last few decades, which is a big health risk [37]. Therapeutic agents that are currently approved to treat malignant skin cancers have serious side effects, so it is important to come up with new therapeutic agents that work better and have fewer side effects [38,39]. Lung cancer is the most common type of cancer, and it kills and sickens many people all over the world. It is getting worse every day, and it is thought that about 10,000 new cases will happen every year [40]. In addition, it is the second most common non-communicable disease, with 50% of men and 30% of women having it [41,42].
In the present study, the cytotoxic activity was studied by taking different concentrations (10–50 µg) of aqueous leaf extract of R. apiculata and its synthesized AgNPs in A375 (Skin cancer), A549 (Lung cancer), and KB-3 (oral cancer) cell lines. Untreated and standard drug cisplatin-treated cells were taken as negative and positive groups. The silver nanoparticles showed significant activity with a high percentage of cell death and a lower percentage of cell viability in all the tested cell lines. On comparison within the tested group of cancer cell lines, the AgNPs showed a higher activity in oral cancer followed by skin cancer and then lung cancer. These results are consistent with previous studies, which reported a higher cytotoxic activity of the synthesized nanoparticles [16,24].
The skin is the body’s largest organ and is responsible for maintaining bodily homeostasis and protecting the body from pathogenic bacteria, UV radiation, and toxins, among other things [43]. Wounds form when the skin’s integrity is disturbed, and they usually recover in three months. Chronic wounds are defined as wounds that do not heal within three months for various reasons [44]. Chronic wounds, a silent killer, are one of the many risks that older people face. Non-healing chronic wounds affect not just elderly people, but also people with diabetes, nephropathies, cardiovascular diseases, and other lifestyle conditions [44]. A persistent wound that does not heal reduces an individual’s productivity and places a significant financial burden on the individual as well as the healthcare system [45]. The most commonly used medications to treat wounds in impoverished nations are cetrimide solution, sodium hypochloride, chlorhexidine, and others. These drugs have been shown to be ineffective and have negative effects when taken for long periods [46,47]. Burn patients are sensitive to infections because severe thermal injury damages the skin’s surface barrier and causes an immunological condition [48].
In the present study, the in vitro wound healing activity of aqueous leaf extract of R. apiculata and its synthesized AgNPs was studied by using scratch assay against a non-cancerous fibroblast cell line L929. The cell migration results showed an increase in the cell migration in the standard- and AgNP-treated cells than the aqueous leaf extract of R. apiculata. The standard drug ascorbic acid showed higher cell migration activity, followed by the AgNPs, the plant extract, and the untreated group. In the case of the wound closure study, the standard drug ascorbic acid showed 96.26% of wound closure, whereas the AgNPs and aqueous leaf extract of R. apiculata showed 82.79% and 75.23%, respectively, whereas for the untreated group it was found to be 9.13%. These results are consistent with the findings of Veeraraghavan et al., 2021, who reported that silver nanoparticles from aqueous extract of Scutellaria barbata had potent wound healing activity confirmed with a wound scratch assay on fibroblast cells (L929) [49]
The emerging biochemical applications of nanotechnology are focused on the development of nanoparticles with enhanced antioxidant and antibacterial properties to combat degenerative diseases such as Alzheimer’s and cancer, among others [50,51]. Due to their unique physiochemical properties, metal nanoparticles have received a lot of attention and are now a hot topic for research in fields such as sensors, imaging, cosmetics, cancer therapy, and drug delivery [52]. When silver nanoparticles were invented, they altered the way silver was used in the medical industry [44]. Increasingly, silver nanoparticles are being used in wound dressings, medicine transporters, and even in artificial implantations because of their antibacterial properties [53,54].
AgNPs toxicity to human tissues has been studied extensively in recent years, and it has been found safe for medicinal formulations [55]. A recent review has highlighted the applications of AgNPs in the pharmaceutical and cosmetic industry, tissue engineering, anti-infective therapy and wound care, food, and the textile industry [56]. The present study’s findings are consistent with those of previous studies that have reported the various biomedical applications of AgNPs [57,58,59,60]. As a result, nanotechnology is significantly advancing healthcare field. Researchers use nanoparticles in drug delivery systems, medical imaging, and tumor targeting. Nanoparticle-based medicines have several uses; they can both detect cancers and transport drugs to treat them [58,59].

4. Materials and Methods

4.1. Collection of Plant Material

The plant material (leaves) was collected from the Anshi jungle region of the Western Ghats, in Uttar Kannada District, Karnataka State, India, in March 2022, and was identified by Dr. Kotresha K, of Karnataka Science College’s Department of Botany, Dharwad, Karnataka, by consulting the voucher specimen that is deposited in Karnataka Science College, Dharwad, Karnataka. The leaves were shade-dried, and a motorized grinder was used to reduce the dried leaves into a coarse powder. The powder was maintained in sealed containers at room temperature for further use. All the chemicals and solvents used in this research were purchased from Hi-media in India and were of analytical quality.

4.2. Preparation of Plant Extract

For 48 h, a Soxhlet device was used to extract 25 gm of powdered leaves in 1000 mL of distilled water. The above procedure was repeated for four batches, i.e., 4000 mL of distilled water and 100 gm of powdered leaves were used for the extraction process. The resulting aqueous extract was concentrated using a rotary evaporator. The subsequently concentrated extract was then dried in desiccators to give a final yield of 3.8 g of dried extract and kept in an airtight bottle at 4 °C for further use. The percentage yield was calculated using the following formula: % Yield = R/S 100, where R = extracted weight by leaf residue and S = initial sample weight. AgNPs were synthesized using the R. apiculata aqueous extract as a reductant and stabilizer [61].

4.3. Qualitative Analysis of Metabolites

Following the procedure described by Deepti et al. (2012): the crude aqueous leaf extract of R. apiculata was qualitatively tested for the presence of various groups of metabolites, including flavonoids, alkaloids, phenols, glycosides, lignins, sterols, saponins, anthraquinones, tannins, and reducing sugars [62].

4.4. Estimation of Total Phenolic Content

Spectrophotometry was used to determine the total phenolics in the plant extract (Singleton et al., 1999) [63]. Calibrating curves for gallic acid (G.A.) were made in the range of 20–100 µg/mL. Lastly, the phenolic concentrations were changed into gallic acid equivalents, i.e., µg GA/g of dry weight (dw) of the extract. The standard calibration curve (Y = 0.001X + 0.113) was used to determine the total amount of phenolics.

4.5. Estimation of Flavonoids Content

The amount of flavonoids present in the plant extract was determined using the method described by Chang et al., 2002 [64] using quercetin as a reference standard, and the absorbance of the sample was quantified at 415 nm using a UV-VIS spectrophotometer.

4.6. Synthesis of Silver Nanoparticles

A total of 1 mL of R. apiculata leaf extract (concentration 50 mg/mL) was added to 10 mL of 1 mM AgNO3 aqueous solution (ratio 1:10) and shaken vigorously for 30 s. The complete reaction mixing procedure was conducted in a dark environment at room temperature (26–27 °C) to minimize unwanted photochemical reactions. The oxidation/reduction process was visible after the colorless reaction mixture had been incubated and reacted for the required time [65]. An aqueous mixture containing AgNPs was centrifuged at 10,000 rpm for 10 min and then re-dispersed in double-distilled water to remove the remaining aqueous extract from the freshly synthesized AgNPs, which were allowed to dry in powder [66]. The AgNP synthesis was performed on a pilot scale to optimize the conditions. Later on, the process was scaled-up for the synthesis of R. apiculata AgNPs in a single batch.

4.7. Characterization of Newly Synthesized AgNPs

All of the characterizations and bioassays performed in this investigation used a single batch of the synthesized R. apiculata AgNPs. An array of analytical methods were employed to characterize the produced AgNPs. These included FTIR and U.V.–visible analysis; energy dispersive X-ray analysis; scanning electron microscopy; zeta potential, and particle size analyzer.

4.7.1. U.V.–Visible Spectroscopy-Based Analysis

To confirm the colloidal solution’s reduction in silver ions, a U.V.–visible spectroscopy (U-3310, Hitachi, Tokyo, Japan), was used to examine the U.V. spectrum of 1 mL of an aliquot sample in a quartz cuvette, scanning for wavelengths between 200 and 700 nanometers, in comparison to distilled water as a control and 1 mM AgNO3 as a blank [67].

4.7.2. FTIR-Based Analysis

To identify the functional groups (bio-groups) that bind to the silver surface and play a role in the creation of AgNPs, FTIR spectroscopy was utilized (S700, Nicolet, MA, USA). After 72 h of incubation, the reaction mixtures were centrifuged three to four times at 10,000 rpm for 15 min to separate the AgNPs. Deionized water was used to replace the supernatant, and the particles were powdered and stored. The dried AgNPs were pelleted with potassium bromide in 1:100 ratios and submitted to FTIR analysis [68,69].

4.7.3. Scanning-Electron-Microscopy-Based Analysis

Scanning electron microscopy (JSM-IT 500, Jeol, Boston, MA, USA), was used to determine the surface morphology of nanoparticles. After a 4- to 6-h reaction, the sample was prepared by centrifuging a colloidal solution at 10,000 rpm for five minutes. The pellet was re-centrifuged and re-dispersed in deionized water, a procedure carried out numerous times before the dry pellet was obtained. Once the AgNPs had been cleaned, they were suspended using sonication for 5–10 min, one cycle at a time. Carbon-coated grids were then used to set the suspension’s drop on. The sample was entirely dried under light. SEM analysis was performed on the prepared sample [69].

4.7.4. Energy Dispersive X-ray

In this study, reduced AgNPs were dried on a carbon-coated copper grid, then exposed to EDX (JSM-IT 500, Jeol, Boston, MA, USA), and the elemental composition of the reduced AgNPs was determined using this approach [68].

4.7.5. Zeta Potential Observations of N.P.s

The zeta potential of the colloidal N.P.s may be employed to gather further information on their stability. The zeta potential amplitude suggests the possible colloid stability based on its measurement. According to Meléndrez and colleagues (2010) [70], particles with zeta potentials more positive than +30 mV or more negative than −30 mV are normally considered stable. With the laser zeta meter, we examined potentials on the surface (Malvern zeta seizer 2000, Malvern, Worcestershire, UK). NaCl was used as a suspending electrolyte solution (2 10–2 M NaCl) to dilute the liquid nanoparticle samples (5 mL). After that, the pH was set to the desired level. For 30 min, the samples were shaken vigorously. Metal particles’ zeta potential and equilibrium pH were obtained after shaking. The silver nanoparticles’ surface potential was measured using a zeta potential analyzer. Each measurement was based on an average of three measurements.

4.7.6. Particle Size Analyzer

The PSA analysis was performed on a lyophilized and ultrasonicated sample (SZ-100, Horiba, Kyoto, Japan) to determine the samples’ particle sizes [68].

4.7.7. X-ray Diffraction (XRD) Analysis

In the present study, the synthesized silver nanoparticles from aqueous leaf extract of R. apiculata were subjected to XRD analysis (Smart Lab SE, Rigaku, Tokyo, Japan) to determine the nature and average size of the nanoparticles [23].

4.8. In Vitro Measurement of Antioxidant Activity

4.8.1. Ferric Ion-Reducing Antioxidant Power Assay (FRAP)

According to Oyaizu. (1986) [71] with a minor adjustment, the ferric ions’ reducing power was assessed. Concentrations of aqueous extract of R. apiculata leaf and the synthesized AgNPs ranged from 100, 200, 300, 400, and 500 µg/mL. The mixture was then incubated for 30 min at 50 degrees Celsius with 2.5 milliliters of 20 mM phosphate buffer and 2.5 milliliters of 1 percent w/v potassium ferricyanide. It was then cooled and incubated for another 10 min before adding 2.5 mL trichloroacetic acid and 0.5% ferric chloride to the mixture. A UV-VIS spectrophotometer was used to detect the absorbance at 700 nm. Ascorbic acid was utilized as a benchmark. Each sample was tested three times in triplicates.

4.8.2. Hydrogen Peroxide Scavenging Assay

R. apiculata leaf extracts and their generated AgNPs were tested for their capacity to scavenge hydrogen peroxide using ascorbic acid as a reference to evaluate their antioxidant activity. A total of 0.6 mL of phosphate buffer (pH-7.4) containing 4 mM H2O2 was added to 0.5 mL of standard ascorbic acid at a known concentration, as well as to tubes containing plant extracts at various concentrations ranging from 100 to 500 µg/mL in phosphate buffer (pH-7.4). We assessed the solution’s absorbance at 230 nm after ten minutes using a phosphate buffer and a hydrogen-peroxide-free blank solution. Phosphate buffer was substituted for the sample or standard in the control preparation. Each sample was tested three times. The formula approach was used to compute the percentage of inhibition.
Percentage of inhibition % = Ac − At/Ac × 100

4.8.3. DPPH Free-Radical-Scavenging Ability Assay

The free-radical-scavenging activities of the R. apiculata aqueous leaf extract and its produced AgNPs were evaluated using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical test [72]. A total of 3 mL of 0.1 mM DPPH in methanol solution was added to each aqueous extract and its AgNPs. Tubes were vigorously shaken and left at room temperature for 30 min in the dark. At 517 nm, absorbance was measured using a UV-VIS spectrophotometer. The control was distilled water, and the standard was ascorbic acid. Following the below formula, each sample’s ability to scavenge DPPH was determined.
% inhibition = Ac − At/Ac × 100
where in Ac is the absorbance of the control and At is the absorbance of the test sample. Experiments were carried out in triplets. All of the substances that were tested had their IC50 values determined. A higher level of free radical activity was indicated by lower absorbance of the reaction mixture.

4.8.4. Phosphomolybdenum (PM) Assay

According to Prieto et al., 1999 [73], the standard PM test was used to determine the total antioxidant activity. Leaf extracts and the AgNPs were added to each test tube at a concentration of 100, 200, 300, 400, and 500 µg/mL, and each tube included 3 mL of distilled water and 1 mL of molybdate reagent. For 90 min, these tubes were held at 95 °C. A 695 nm absorbance reading was taken after the reaction mixture was adjusted to room temperature for 20–30 min. Ascorbic acid was utilized as a standard.

4.9. Evaluation of In Vitro Anti-Inflammatory Activity

Using the protein denaturation technique published by Padmanabhan et al., 2012 [74], the anti-inflammatory efficacy of R. apiculata aqueous leaf extract and its AgNPs was investigated. The potent non-steroidal anti-inflammatory drug diclofenac sodium was used as a standard drug. A total of 2 mL of synthesized AgNP (100 μg/mL) was added to 2.8 mL of phosphate-buffered saline (pH 6.4) and 2 mL of egg albumin (from fresh hen’s egg (1 mM)) in the reaction mixture, which was incubated for 15 min at 27 ± 1 °C. The mixture was heated in a water bath at 70 °C for ten minutes to produce denaturation. After cooling to room temperature, the absorbance was measured at 660 nm. Each experiment was carried out three times over. To calculate the percentage of protein denaturation inhibition, the following formula was used:
% inhibition= Ac−At/Ac × 100
where, At = absorbance of test sample; Ac = absorbance of control.

4.10. Determination of the Cytotoxic Activity of Aqueous Leaf Extract of R. apiculata and Its Synthesized Silver Nanoparticles Using MTT Assay

A standard colorimetric MTT assay using 3-(4,5-dimethylthiazol- 2-yl)-2,5-dimethyl tetrazolium bromide dye (Sigma, St. Louis, MO, U.S.A.) was used by Carmichael et al. [75] to test the effect of R. apiculata aqueous leaf extract and synthesized silver nanoparticles on the viability of non-cancerous fibroblast cells L929 (1987). Based on dose–response curves created for each cell line, an IC50 value for the concentration of the test medication needed to suppress cell growth by 50% (IC50) was computed. Mitochondrial dehydrogenase of undamaged cells reduces MTT to a purple formazan residue [76].
Inhibition Percentage = OD of Test sample ÷ OD of control × 100

4.11. In Vitro Wound Healing Study by Using Scratch Assay Test

Plant extract and silver nanoparticles were examined for the migration capabilities of the L929 cell line [77]. Animal cell culture plates with DMEM medium supplemented with 10% FBS and 2 percent penstrip antibiotic were used to start the cell culture process. After achieving a cell density of roughly 50,000, a sterile 100 μL plastic pipette tip scratch was used to generate a monolayer confluent of cells. PBS solution was used to wash away cell debris. Untreated cells were used as a negative control, whereas standard ascorbic acid was used as a positive control. A 24-h incubation period at 37 °C with 5% CO2 was then carried out on the cells. To evaluate relative cell migration and wound closure, the scratched cell layers were incubated for various lengths of time: 0 h, 6 h, 12 h, and 24 h. MagVision Software was used to calibrate 4× magnification to assess the gap distance. Applying the following formula, wound closure and migration rates were calculated:
Wound closure (%) = A0h − ATh/ATh × 100
Rm (Rate of migration) = Wi—Wf/T
where A0h represents the wound’s initial size, ATh represents the wound’s size after h hours, Rm represents the rate of migration (m/h), Wi represents the initial wound width (μm), Wf represents the final wound width (μm), and T represents the duration of migration (hour).

4.12. Statistical Analysis

All experiments were conducted in triplicate (n = 3), and the results were reported as the mean standard deviation and the standard error of the mean. Using a one-way ANOVA analysis in the IBM SPSS Version-20, we determined the differences in means between the various groups.

5. Conclusions

The present study is one of the first to report the R. apiculata AgNPs wound healing potential and cytotoxic activity against the A375 (Skin cancer), A549 (Lung cancer), and KB-3-1 (Oral cancer) cell lines. In the present study, aqueous leaf extract of R. apiculata was used as a reducing agent for the synthesis of silver nanoparticles from silver nitrate. The synthesized silver nanoparticles were characterized by several techniques such as SEM-EDX, FTIR, a particle size analyzer, XRD, and zeta potential. All the analytical techniques confirmed the synthesis of silver nanoparticles. Antioxidant, anti-inflammatory, and cytotoxicity investigations against cancer cell-lines revealed that the AgNPs had significantly higher activity than the plant extract. In the case of the in vitro wound healing activity, the AgNPs showed more potent cell migration and wound closure than the plant extract. In future, R. apiculata should be further explored to unmask its therapeutic potential and the mechanistic pathways of AgNPs should be studied in detail in in vivo animal models. In light of these encouraging findings, we recommend further research into the following areas: the effect of harvesting location, season, and quantity on metabolite, phenolic, and flavonoid presence; the feasibility of performing at least one additional scale-up synthesis of an additional extract to demonstrate effects similar to those reported in the manuscript; and the stability of extracts and nanoparticles during storage to ensure its safety.

Author Contributions

Conceptualization, S.A.A., M.Y.A., M.H.M., I.A.S. and A.K.S.; Data curation, A.M.A.; Formal analysis, M.A.B., M.H.M. and J.H.H.; Funding acquisition, S.A.A.; Investigation, A.M.A., I.A.S., A.K.S., J.H.H. and V.K.; Methodology, M.Y.A., M.H.M. and A.K.S.; Project administration, S.A.A.; Resources, M.A.B., J.H.H. and V.K.; Supervision, M.A.B. and I.A.S.; Visualization, V.K.; Writing—original draft, I.A.S. and A.K.S.; Writing—review & editing, S.A.A., A.M.A., M.Y.A. and M.H.M. All authors have read and agreed to the published version of the manuscript.

Funding

The authors are thankful to the Deanship of Scientific Research at Najran University for funding this work under the Research Groups Funding program grant code (NU/RG/MRC/11/4).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data related to this research is included in the results section.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds R. apiculata extract and R. apiculata AgNPs are available from the authors.

References

  1. Jain, S.; Mehata, M.S. Medicinal Plant Leaf Extract and Pure Flavonoid Mediated Green Synthesis of Silver Nanoparticles and Their Enhanced Antibacterial Property. Sci. Rep. 2017, 7, 15867. [Google Scholar] [CrossRef]
  2. Muddapur, U.M.; Alshehri, S.; Ghoneim, M.M.; Mahnashi, M.H.; Alshahrani, M.A.; Khan, A.A.; Iqubal, S.M.S.; Bahafi, A.; More, S.S.; Shaikh, I.A.; et al. Plant-Based Synthesis of Gold Nanoparticles and Theranostic Applications: A Review. Molecules 2022, 27, 1391. [Google Scholar] [CrossRef]
  3. Cele, T. Preparation of Nanoparticles. In Engineered Nanomaterials—Health and Safety; IntechOpen: London, UK, 2020; ISBN 9781838804114. [Google Scholar]
  4. Adlim, A. Preparations and Application of Metal Nanoparticles. Indones. J. Chem. 2010, 6, 1–10. [Google Scholar] [CrossRef]
  5. Iravani, S.; Korbekandi, H.; Mirmohammadi, S.V.; Zolfaghari, B. Synthesis of Silver Nanoparticles: Chemical, Physical and Biological Methods. Res. Pharm. Sci. 2014, 9, 385–406. [Google Scholar]
  6. Li, X.; Xu, H.; Chen, Z.-S.; Chen, G. Biosynthesis of Nanoparticles by Microorganisms and Their Applications. J. Nanomater. 2011, 2011, 270974. [Google Scholar] [CrossRef]
  7. Peralta-Videa, J.R.; Huang, Y.; Parsons, J.G.; Zhao, L.; Lopez-Moreno, L.; Hernandez-Viezcas, J.A.; Gardea-Torresdey, J.L. Plant-Based Green Synthesis of Metallic Nanoparticles: Scientific Curiosity or a Realistic Alternative to Chemical Synthesis? Nanotechnol. Environ. Eng. 2016, 1, 4. [Google Scholar] [CrossRef]
  8. Rafique, M.; Sadaf, I.; Rafique, M.S.; Tahir, M.B. A Review on Green Synthesis of Silver Nanoparticles and Their Applications. Artif. Cells Nanomed. Biotechnol. 2017, 45, 1272–1291. [Google Scholar] [CrossRef]
  9. Abdelghany, T.M.; Al-Rajhi, A.M.H.; Al Abboud, M.A.; Alawlaqi, M.M.; Ganash Magdah, A.; Helmy, E.A.M.; Mabrouk, A.S. Recent Advances in Green Synthesis of Silver Nanoparticles and Their Applications: About Future Directions. A Review. Bionanoscience 2018, 8, 5–16. [Google Scholar] [CrossRef]
  10. Raj, S.; Trivedi, R.; Soni, V. Biogenic Synthesis of Silver Nanoparticles, Characterization and Their Applications—A Review. Surfaces 2021, 5, 3. [Google Scholar] [CrossRef]
  11. Rahim, A.A.; Rocca, E.; Steinmetz, J.; Jain Kassim, M.; Sani Ibrahim, M.; Osman, H. Antioxidant Activities of Mangrove Rhizophora Apiculata Bark Extracts. Food Chem. 2008, 107, 200–207. [Google Scholar] [CrossRef]
  12. Baishya, S.; Banik, S.K.; Choudhury, M.D.; Das Talukdar, D.; Das Talukdar, A. Therapeutic Potentials of Littoral Vegetation: An Antifungal Perspective. In Biotechnological Utilization of Mangrove Resources; Elsevier: Berlin/Heidelberg, Germany, 2020; pp. 275–292. ISBN 9780128195321. [Google Scholar]
  13. Mitra, S.; Naskar, N.; Chaudhuri, P. A Review on Potential Bioactive Phytochemicals for Novel Therapeutic Applications with Special Emphasis on Mangrove Species. Phytomed. Plus 2021, 1, 100107. [Google Scholar] [CrossRef]
  14. Antony, J.J.; Sivalingam, P.; Siva, D.; Kamalakkannan, S.; Anbarasu, K.; Sukirtha, R.; Krishnan, M.; Achiraman, S. Comparative Evaluation of Antibacterial Activity of Silver Nanoparticles Synthesized Using Rhizophora Apiculata and Glucose. Colloids Surf. B Biointerfaces 2011, 88, 134–140. [Google Scholar] [CrossRef] [PubMed]
  15. Zhang, H.; Jacob, J.A.; Jiang, Z.; Xu, S.; Sun, K.; Zhong, Z.; Varadharaju, N.; Shanmugam, A. Hepatoprotective Effect of Silver Nanoparticles Synthesized Using Aqueous Leaf Extract of Rhizophora Apiculata. Int. J. Nanomed. 2019, 14, 3517–3524. [Google Scholar] [CrossRef] [PubMed]
  16. Wen, X.; Wang, Q.; Dai, T.; Shao, J.; Wu, X.; Jiang, Z.; Jacob, J.A.; Jiang, C. Identification of Possible Reductants in the Aqueous Leaf Extract of Mangrove Plant Rhizophora Apiculata for the Fabrication and Cytotoxicity of Silver Nanoparticles against Human Osteosarcoma MG-63 Cells. Mater. Sci. Eng. C Mater. Biol. Appl. 2020, 116, 111252. [Google Scholar] [CrossRef]
  17. Ramalingam, V.; Rajaram, R. Enhanced Antimicrobial, Antioxidant and Anticancer Activity of Rhizophora Apiculata: An Experimental Report. 3 Biotech 2018, 8, 200. [Google Scholar] [CrossRef]
  18. Alshabi, A.M.; Shaikh, I.A.; Asdaq, S.M.B. The Antiepileptic Potential of Vateria Indica Linn in Experimental Animal Models: Effect on Brain GABA Levels and Molecular Mechanisms. Saudi J. Biol. Sci. 2022, 29, 3600–3609. [Google Scholar] [CrossRef]
  19. Pandiarajan, J.; Krishnan, M. Properties, synthesis and toxicity of silver nanoparticles. Environ. Chem. Lett. 2017, 15, 387–397. [Google Scholar] [CrossRef]
  20. Ahmed, S.; Ahmad, M.; Swami, B.L.; Ikram, S. A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise. J. Adv. Res. 2016, 7, 17–28. [Google Scholar] [CrossRef]
  21. Daphne, J.; Francis, A.; Mohanty, R.; Ojha, N.; Das, N. Green synthesis of antibacterial silver nanoparticles using yeast isolates and its characterization. Res. J. Pharm. Technol. 2018, 11, 83–92. [Google Scholar] [CrossRef]
  22. Anandalakshmi, K.; Venugobal, J.; Ramasamy, V. Characterization of silver nanoparticles by green synthesis method using Pedalium murex leaf extract and their antibacterial activity. Appl. Nanosci. 2016, 6, 399–408. [Google Scholar] [CrossRef]
  23. Rashid, T.M.; Nayef, U.M.; Jabir, M.S.; Mutlak, F.A.-H. Synthesis and Characterization of Au:ZnO (Core:Shell) Nanoparticles via Laser Ablation. Optik 2021, 244, 167569. [Google Scholar] [CrossRef]
  24. Lotfi-Attari, J.; Pilehvar-Soltanahmadi, Y.; Dadashpour, M.; Alipour, S.; Farajzadeh, R.; Javidfar, S.; Zarghami, N. Co-delivery of curcumin and chrysin by polymeric nanoparticles inhibit synergistically growth and hTERT gene expression in human colorectal cancer cells. Nutr. Cancer 2017, 69, 1290–1299. [Google Scholar] [CrossRef]
  25. Firoozi, M.; Rezapour-Jahani, S.; Shahvegharasl, Z.; Anarjan, N. Ginger essential oil nanoemulsions: Preparation and physicochemical characterization and antibacterial activities evaluation. J. Food Process Eng. 2020, 43, e13434. [Google Scholar] [CrossRef]
  26. Jyoti, K.; Baunthiyal, M.; Singh, A. Characterization of silver nanoparticles synthesized using Urtica dioica Linn. leaves and their synergistic effects with antibiotics. J. Radiat. Res. Appl. Sci. 2016, 9, 217–227. [Google Scholar] [CrossRef]
  27. Rajkumar, V.; Guha, G.; Kumar, R.A.; Lazar, M. Evaluation of antioxidant activities of Bergenia ciliata rhizome. Rec. Nat. Prod. 2010, 4, 38. [Google Scholar]
  28. Carocho, M.; Ferreira, I.C. A review on antioxidants, prooxidants and related controversy: Natural and synthetic compounds, screening and AAnalysis methodologies and future perspectives. Food Chem. Toxicol. 2013, 51, 15–25. [Google Scholar] [CrossRef]
  29. Chung, J.H.; Seo, J.Y.; Choi, H.R.; Lee, M.K.; Youn, C.S.; Rhie, G.E.; Cho, K.H.; Kim, K.H.; Park, K.C.; Eun, H.C. Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J. Investig. Dermatol. 2001, 117, 1218–1224. [Google Scholar] [CrossRef]
  30. Roth, S.H. Coming to terms with nonsteroidal anti-inflammatory drug gastropathy. Drugs 2012, 72, 873–879. [Google Scholar] [CrossRef]
  31. Blomqvist, P.; Feltelius, N.; Ekbom, A.; Klareskog, L. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions. J. Reumatol. 2000, 27, 1171–1177. [Google Scholar]
  32. Ishiyama, M.; Tominaga, H.; Shiga, M.; Sasamoto, K.; Ohkura, Y.; Ueno, K. A combined assay of cell vability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharm. Bull. 1996, 19, 1518–1520. [Google Scholar] [CrossRef]
  33. Rufen, L.; Zhen, C.; Na, R.; Yixuan, W.; Yujia, W.; Fengye, Y. Biosynthesis of silver oxide nanoparticles and their photocatalytic and antimicrobial activity evaluation for wound healing applications in nursing care. J. Photochem. Photobiol. B 2019, 199, 111593. [Google Scholar]
  34. Suganya, S.; Ishwarya, S.; Jayakumar, S.; Govindarajan, M.; Alharbi, N.S.; Kadaikanna, S.; Khaled, J.M.; Al-Anbir, M.N.; Vaseeharan, B. New insecticides and antimicrobials derived from Sargassum wightii and Halimeda gracillis seaweeds: Toxicity against mosquito vectors and antibiofilm activity against microbial pathogens. S. Afr. J. Bot. 2019, 125, 466–480. [Google Scholar] [CrossRef]
  35. Vijayakumar, S.; Malaikozhundan, B.; Saravanakumar, S.; Duran-Lara, E.F.; Wang, M.H.; Vaseeharan, B. Garlic clove extract assisted silver nanoparticle- Antibacterial, antibiofilm, antihelminthic, anti-inflammatory, anticancer and ecotoxicity assessment. J. Photochem. Photobiol. B Biol. 2019, 198, 111558. [Google Scholar] [CrossRef] [PubMed]
  36. Anna, R.F.; Małgorzata, K.L.; Victor, S.; Silvia, I.; Mnuel, A.; Agnieszka, K.; Grazyna, S. Development of noncytotoxic silver–chitosan nanocomposites for efficient control of biofilm forming microbes. RSC Adv. 2017, 7, 52398. [Google Scholar]
  37. Greinert, R.; de Vries, E.; Erdmann, F.; Espina, C.; Auvinen, A.; Kesminiene, A.; Schüz, J. European Code against Cancer 4th edition: Ultraviolet radiation and cancer. Cancer Epidemiol. 2015, 39, S75–S83. [Google Scholar] [CrossRef] [Green Version]
  38. Zhao, B.; He, Y.-Y. Recent advances in the prevention and treatment of skin cancer using photodynamic therapy. Expert Rev. Anticancer. Ther. 2010, 10, 1797–1809. [Google Scholar] [CrossRef]
  39. Zhao, Q.-H.; Zhang, Y.; Liu, Y.; Wang, H.-L.; Shen, Y.-Y.; Yang, W.-J.; Wen, L.-P. Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery. Med. Oncol. 2009, 27, 203–212. [Google Scholar] [CrossRef]
  40. Malvin, S.S.; Sujin, J.; Selvarajan, E.; Thangavel, M.; Arivazhagan, P. Biosynthasized silver nanoparticle using Bacillus amyloliquefaciens: Application of cytotoxicity effect on A549 cell line and photocatalytic degradation of p-nitrophenol. J. Photochem. Photobiol. B Biol. 2020, 202, 111642. [Google Scholar]
  41. Rajivgandhi, G.; Muneeswaran, T.; Maruthupandy, M.; Ramakritinan, C.; Saravanan, K.; Ravikumar, V.; Manoharan, N. Antibacterial and anticancer potential of marine endophytic actinomycetes Streptomyces coeruleorubidus GRG 4 (KY457708) compound against colistin resistant uropathogens and A549 lung cancer cells. Microb. Pathog. 2018, 125, 325–335. [Google Scholar] [CrossRef]
  42. Wong, M.C.S.; Lao, X.Q.; Ho, K.-F.; Goggins, W.B.; Tse, S.L.A. Incidence and mortality of lung cancer: Global trends and association with socioeconomic status. Sci. Rep. 2017, 7, 14300. [Google Scholar] [CrossRef]
  43. Percival, S.L.; Suleman, L.; Vuotto, C.; Donelli, G. Healthcare-associated infections, medical devices and biofilms: Risk, tolerance and control. J. Med. Microbiol. 2015, 64, 323–334. [Google Scholar] [CrossRef] [PubMed]
  44. Järbrink, K.; Ni, G.; Sönnergren, H.; Schmidtchen, A.; Pang, C.; Bajpai, R.; Car, J. The humanistic and economic burden of chronic wounds: A protocol for a systematic review. Syst. Rev. 2017, 6, 15. [Google Scholar] [CrossRef] [PubMed]
  45. Augustin, M.; Brocatti, L.K.; Rustenbach, S.J.; Schäfer, I.; Herberger, K. Cost-ofillness of leg ulcers in the community. Int Wound J. 2014, 11, 283–292. [Google Scholar] [CrossRef]
  46. Moore, D. Hypochlorites: A review of the evidence. J. Wound Care 1992, 1, 44–53. [Google Scholar] [CrossRef] [PubMed]
  47. Toppo, F.S.; Pawar, R.S. Novel drug delivery strategies and approaches for wound healing managements. J. Crit. Rev. 2015, 2, 12–20. [Google Scholar]
  48. Church, D.; Elsayed, S.; Reid, O.; Winston, B.; Lindsay, R. Burn wound infections. Clin. Microbiol. Rev. 2006, 19, 403–434. [Google Scholar] [CrossRef]
  49. Veeraraghavan, V.P.; Periadurai, N.D.; Karunakaran, T.; Hussain, S.; Surapaneni, K.M.; Jiao, X. Green Synthesis of Silver Nanoparticles from Aqueous Extract of Scutellaria Barbata and Coating on the Cotton Fabric for Antimicrobial Applications and Wound Healing Activity in Fibroblast Cells (L929). Saudi J. Biol. Sci. 2021, 28, 3633–3640. [Google Scholar] [CrossRef]
  50. Nazem, A.; Mansoori, G.A. Nanotechnology solutions for Alzheimer’s disease: Advances in research tools, diagnostic methods and therapeutic agents. J. Alzheimer’s Dis. 2008, 13, 199–223. [Google Scholar] [CrossRef]
  51. Sanpui, P.; Chattopadhyay, A.; Ghosh, S.S. Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier. Appl. Mater. Interfaces 2011, 3, 218–228. [Google Scholar] [CrossRef]
  52. Mody, V.V.; Siwale, R.; Singh, A.; Mody, H.R. Introduction to metallic nanoparticles. J. Pharm. Bioallied. Sci. 2010, 2, 282–289. [Google Scholar] [CrossRef]
  53. Haider, A.; Kang, I.K. Preparation of silver nanoparticles and their industrial and biomedical applications: A comprehensive review. Adv. Mater. Sci. Eng. 2015, 165, 257. [Google Scholar] [CrossRef]
  54. Liao, C.; Li, Y.; Tjong, S.C. Bactericidal and cytotoxic properties of silver nanoparticles. Int. J. Mol. Sci. 2019, 20, 449. [Google Scholar] [CrossRef] [PubMed]
  55. Ontong, J.C.; Paosen, S.; Shankar, S.; Voravuthikunchai, S.P. Eco-friendly synthesis of silver nanoparticles using Senna alata bark extract and its antimicrobial mechanism through enhancement of bacterial membrane degradation. J. Microbiol. Methods 2019, 165, 105692. [Google Scholar] [CrossRef] [PubMed]
  56. Gherasim, O.; Puiu, R.A.; Bîrcă, A.C.; Burdușel, A.-C.; Grumezescu, A.M. An Updated Review on Silver Nanoparticles in Biomedicine. Nanomaterials 2020, 10, 2318. [Google Scholar] [CrossRef]
  57. Burdușel, A.-C.; Gherasim, O.; Grumezescu, A.M.; Mogoantă, L.; Ficai, A.; Andronescu, E. Biomedical Applications of Silver Nanoparticles: An Up-to-Date Overview. Nanomaterials 2018, 8, 681. [Google Scholar] [CrossRef]
  58. Arif, R.; Uddin, R. A Review on Recent Developments in the Biosynthesis of Silver Nanoparticles and Its Biomedical Applications. Med. Devices Sens. 2021, 4, e10158. [Google Scholar] [CrossRef]
  59. Zhang, X.-F.; Liu, Z.-G.; Shen, W.; Gurunathan, S. Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches. Int. J. Mol. Sci. 2016, 17, 1534. [Google Scholar] [CrossRef]
  60. Shaikh, I.A.; Muddapur, U.M.; Bagewadi, Z.K.; Chiniwal, S.; Ghoneim, M.M.; Mahnashi, M.H.; Alsaikhan, F.; Yaraguppi, D.; Niyonzima, F.N.; More, S.S.; et al. Characterization of Bioactive Compounds from Acacia concinna and Citrus limon, Silver Nanoparticles’ Production by A. concinna Extract, and Their Biological Properties. Molecules 2022, 27, 2715. [Google Scholar] [CrossRef]
  61. Kumar, R.; Roopan, S.M.; Prabhakarn, A.; Khanna, V.G.; Chakroborty, S. Agricultural waste Annona squamosa peel extract: Biosynthesis of silver nanoparticles. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2012, 90, 173–176. [Google Scholar] [CrossRef]
  62. Deepti, K.; Umadevi, P.; Vijayalakshmi, G. Antimicrobial activity and phytochemical analysis of Morinda tinctoria Roxb. leaf extracts. Asian Pac. J. Trop. Biomed. 2012, 2, S1440–S1442. [Google Scholar] [CrossRef]
  63. Singleton, V.L.; Orthofer, R.; Lamuela-Raventós, R.M. [14] Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. In Methods in Enzymology; Academic Press: Cambridge, MA, USA, 1999; Volume 299, pp. 152–178. [Google Scholar]
  64. Chang, C.C.; Yang, M.H.; Wen, H.M.; Chern, J.C. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J. Food Drug Anal. 2002, 10, 178–182. [Google Scholar]
  65. Kannan, R.R.R.; Stirk, W.A.; Van Staden, J. Synthesis of silver nanoparticles using the seaweed Codium capitatum P.C. Silva (Chlorophyceae). S. Afr. J. Bot. 2013, 86, 1–4. [Google Scholar] [CrossRef]
  66. Kumar, B.; Smita, K.; Cumbal, L.; Debut, A. Green synthesis of silver nanoparticles using Andean blackberry fruit extract. Saudi J. Biol. Sci. 2017, 24, 45–50. [Google Scholar] [CrossRef] [PubMed]
  67. Wiley, B.J.; Im, S.H.; Li, Z.Y.; McLellan, J.; Siekkinen, A.; Xia, Y. Maneuvering the surface plasmon resonance of silver nanostructures through shape-controlled synthesis. J. Phys. Chem. B 2006, 110, 15666–15675. [Google Scholar] [CrossRef]
  68. Bahjat, H.H.; Ismail, R.A.; Sulaiman, G.M.; Jabir, M.S. Magnetic Field-Assisted Laser Ablation of Titanium Dioxide Nanoparticles in Water for Antibacterial Applications. J. Inorg. Organomet. Polym. Mater. 2021, 31, 3649–3656. [Google Scholar] [CrossRef]
  69. Jabir, M.S.S.; Nayef, U.M.M.; Abdulkadhim, W.K.; Taqi, Z.J.J.; Sulaiman, G.M.; Sahib, U.I.I.; Al-Shammari, A.M.; Wu, Y.-J.; El-Shazly, M.; Su, C.-C. Fe3O4 Nanoparticles Capped with PEG Induce Apoptosis in Breast Cancer AMJ13 Cells via Mitochondrial Damage and Reduction of NF-ΚB Translocation. J. Inorg. Organomet. Polym. Mater. 2021, 31, 1241–1259. [Google Scholar] [CrossRef]
  70. Meléndrez, M.F.; Cárdenas, G.; Arbiol, J. Synthesis and characterization of gallium colloidal nanoparticles. J. Colloid Interface Sci. 2010, 346, 279–287. [Google Scholar] [CrossRef]
  71. Oyaizu, M. Antioxidative activities of browning reaction prepared from glucosamine. Jpn. J. Nutr. 1986, 44, 307–315. [Google Scholar] [CrossRef] [Green Version]
  72. Ruiz, J.C.R. Free Radical Scavenging Activity. PLoS ONE 2018, 1. [Google Scholar] [CrossRef]
  73. Prieto, P.; Pineda, M.; Aguilar, M. Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: Specific application to the determination of vitamin E. Anal. Biochem. 1999, 269, 337–341. [Google Scholar] [CrossRef]
  74. Padmanabhan, P.; Jangle, S.N. Evaluation of in-vitro anti-inflammatory activity of herbal preparation, a combination of four medicinal plants. Int. J. Basic Appl. Med. Sci. 2012, 2, 109–116. [Google Scholar]
  75. Carmichael, J.; DeGraff, W.G.; Gazdar, A.F.; Minna, J.D.; Mitchell, J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 1987, 47, 936–942. [Google Scholar] [PubMed]
  76. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef]
  77. Fronza, M.; Heinzmann, B.; Hamburger, M.; Laufer, S.; Merfort, I. Determination of the wound healing effect of Calendula extracts using the scratch assay with 3T3 fibroblasts. J. Ethnopharmacol. 2009, 126, 463–467. [Google Scholar] [CrossRef] [PubMed]
Molecules 27 06306 g001 550
Figure 1. Formation of silver nanoparticles after adding aqueous leaf extract of R. apiculata with the change in time.
Figure 1. Formation of silver nanoparticles after adding aqueous leaf extract of R. apiculata with the change in time.
Molecules 27 06306 g001
Molecules 27 06306 g002 550
Figure 2. Silver nanoparticles were confirmed by UV-VIS spectral spectroscopy of colloidal solution.
Figure 2. Silver nanoparticles were confirmed by UV-VIS spectral spectroscopy of colloidal solution.
Molecules 27 06306 g002
Molecules 27 06306 g003 550
Figure 3. SEM images of R. apiculata AgNPs show an uneven shape and a diameter of 35–100 nm.
Figure 3. SEM images of R. apiculata AgNPs show an uneven shape and a diameter of 35–100 nm.
Molecules 27 06306 g003
Molecules 27 06306 g004 550
Figure 4. EDX analysis of R. apiculata AgNPs showing its elemental composition.
Figure 4. EDX analysis of R. apiculata AgNPs showing its elemental composition.
Molecules 27 06306 g004
Molecules 27 06306 g005 550
Figure 5. FTIR analysis of aqueous leaf extract of R. apiculata to determine its functional groups.
Figure 5. FTIR analysis of aqueous leaf extract of R. apiculata to determine its functional groups.
Molecules 27 06306 g005
Molecules 27 06306 g006 550
Figure 6. FTIR analyses of AgNPs synthesized from aqueous leaf extract of R. apiculata to determine functional groups responsible for the bioreduction.
Figure 6. FTIR analyses of AgNPs synthesized from aqueous leaf extract of R. apiculata to determine functional groups responsible for the bioreduction.
Molecules 27 06306 g006
Molecules 27 06306 g007 550
Figure 7. Zeta potential distribution of R. apiculata AgNPs.
Figure 7. Zeta potential distribution of R. apiculata AgNPs.
Molecules 27 06306 g007
Molecules 27 06306 g008 550
Figure 8. Particle size analysis of R. apiculata AgNPs.
Figure 8. Particle size analysis of R. apiculata AgNPs.
Molecules 27 06306 g008
Molecules 27 06306 g009 550
Figure 9. XRD analysis of R. apiculata AgNPs confirming its crystalline nature.
Figure 9. XRD analysis of R. apiculata AgNPs confirming its crystalline nature.
Molecules 27 06306 g009
Molecules 27 06306 g010 550
Figure 10. Morphological changes in L929 after treatment with aqueous leaf extract of R. apiculata and AgNPs.
Figure 10. Morphological changes in L929 after treatment with aqueous leaf extract of R. apiculata and AgNPs.
Molecules 27 06306 g010
Molecules 27 06306 g011 550
Figure 11. Morphological changes in cancer cell lines after treatment with aqueous leaf extract of R. apiculata and AgNPs.
Figure 11. Morphological changes in cancer cell lines after treatment with aqueous leaf extract of R. apiculata and AgNPs.
Molecules 27 06306 g011
Molecules 27 06306 g012 550
Figure 12. Microscopical images illustrating the ability of R. apiculata to heal wounds (in vitro). Images were taken at 0, 6, 12, and 24 h after mice fibroblast cells were cultured in the presence or absence of test and standard drugs.
Figure 12. Microscopical images illustrating the ability of R. apiculata to heal wounds (in vitro). Images were taken at 0, 6, 12, and 24 h after mice fibroblast cells were cultured in the presence or absence of test and standard drugs.
Molecules 27 06306 g012
Table
Table 1. Phytochemical Analysis of aqueous leaf extract of R. apiculata.
Table 1. Phytochemical Analysis of aqueous leaf extract of R. apiculata.
TestsWater Extract
Alkaloids−
Flavonoids+
Glycosides+
Phenols+
Saponins+
Tannins−
Terpenoids+
Steroids−
+: present; −: absent.
Table
Table 2. FRAP assay of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Table 2. FRAP assay of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Sl.NoConcentration
(µL/mL)		Optical Density at 700 nm
Std Ascorbic AcidR. apiculata ExtractAgNPs
11000.46 ± 0.0030.44 ± 0.0030.60 ± 0.036
22000.75 ± 0.0040.48 ± 0.0030.80 ± 0.036
33000.99 ± 0.0040.53 ± 0.0051.03 ± 0.054
44001.13 ± 0.0040.63 ± 0.0031.51 ± 0.017
55001.46 ± 0.0030.86 ± 0.0251.81 ± 0.025 *
Results were performed in triplicates and expressed as mean ± standard error. * One-way ANOVA followed by post Tukey’s test revealed statistically significant differences (p ≤ 0.001) between the groups.
Table
Table 3. H2O2 assay of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Table 3. H2O2 assay of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Sl. NoConcentration
(µg/mL)		SamplesPercentage (%) Inhibition
1100Standard74.46 ± 0.13 *
2100R. apiculata extract63.58 ± 0.44 *
3100AgNPs74.98 ± 0.31 *
Results were performed in triplicates and expressed as mean ± standard error. * One-way ANOVA followed by post Tukey’s test revealed statistically significant differences (p ≤ 0.001) between the groups.
Table
Table 4. DPPH assay of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Table 4. DPPH assay of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Sl.noConcentration
(µg/mL)		Percentage Inhibition
Std Ascorbic AcidR. apiculata ExtractAgNPs
11067.78 ± 0.1743.56 ± 0.7051.04 ± 1.42
22073.65 ± 0.2346.27 ± 0.2355.34 ± 0.98
33078.20 ± 0.3063.64 ± 0.3563.48 ± 1.33
44080.80 ± 0.3572.9833 ± 0.6666.39 ± 0.70
55083.91 ± 0.3577.36 ± 0.3576.74 ± 0.76 *
Results were performed in triplicates and expressed as mean ± standard error. * One-way ANOVA followed by post Tukey’s test revealed statistically significant differences (p ≤ 0.001) between the groups.
Table
Table 5. PM assay of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Table 5. PM assay of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Sl.noConcentration
(µg/mL)		Optical Density at 695 nm
Std Ascorbic AcidR. apiculata ExtractAgNPs
11000.27 ± 0.0040.52 ± 0.0020.71 ± 0.039
2200 0.50 ± 0.0040.79 ± 0.0130.95 ± 0.008
3300 0.68 ± 0.0040.92 ± 0.0111.12 ± 0.044
4400 0.90 ± 0.0031.07 ± 0.0011.37 ± 0.042
5500 1.13 ± 0.0071.27 ± 0.0041.44 ± 0.004 *
Results were performed in triplicates and expressed as mean± standard error. * One-way ANOVA followed by post Tukey’s test revealed statistically significant differences (p ≤ 0.001) between the groups.
Table
Table 6. Anti-inflammatory activity of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Table 6. Anti-inflammatory activity of aqueous leaf extract of R. apiculata and its synthesized AgNPs.
Sl. No.Concentration
(µg/mL)		Treatment% Inhibition
1100 Standard94.24 ± 1.90 *
2500 AgNPs71.65 ± 0.88 *
3500 R. apiculata extract 54.34 ± 3.26 *
Results were performed in triplicates and expressed as mean± standard error. * One-way ANOVA followed by post Tukey’s test revealed statistically significant differences (p ≤ 0.001) between the groups.
Table
Table 7. Cytotoxicity of aqueous leaf extract of R. apiculata and its synthesized AgNPs against L929 cell line.
Table 7. Cytotoxicity of aqueous leaf extract of R. apiculata and its synthesized AgNPs against L929 cell line.
SamplesConcentration in µg/mLPercentage of Cell ViabilityIC50 in µg/mL
R. apiculata extract1097.44 ± 0.00147.47
2084.03 ± 0.005
3073.55 ± 0.001
4058.65 ± 0.001
5046.81 ± 0.002
AgNPs1098.57 ± 0.005105.50
2092.47 ± 0.001
3090.22 ± 0.001
4083.69 ± 0.005
5077.50 ± 0.005
Results were performed in triplicates and represented as mean ± standard error.
Table
Table 8. Anticancer activity of R. apiculata and its synthesized AgNPs against different cancer cell lines.
Table 8. Anticancer activity of R. apiculata and its synthesized AgNPs against different cancer cell lines.
SamplesConcentration in µg/mLPercentage of Cell Viability for A375Percentage of Cell Viability for A549Percentage of Cell Viability for KB-3-1
R. apiculata extract1099.72 ± 0.00199.07 ± 0.00392.20 ± 0.005
2097.35 ± 0.00192.72 ± 0.00188.59 ± 0.015
3091.05 ± 0.00187.36 ± 0.00281.15 ± 0.002
4087.75 ± 0.00183.22 ± 0.00375.51 ± 0.005
5082.69 ± 0.00273.73 ± 0.00267.17 ± 0.001
AgNPs1086.01 ± 0.00595.56 ± 0.00970.95 ± 0.005
2065.60 ± 0.00288.58 ± 0.00258.12 ± 0.005
3054.49 ± 0.00274.76 ± 0.00143.16 ± 0.010
4044.46 ± 0.00567.95± 0.00433.69 ± 0.002
5031.84 ± 0.00456.09 ± 0.01022.59 ± 0.022
Results were performed in triplicates and represented as mean ± SEM.
Table
Table 9. Cell migration of different test samples at different duration.
Table 9. Cell migration of different test samples at different duration.
Sl.NoTest SampleDurationCell Migration in µm
1Untreated6 h2.96
12 h2.50
24 h2.07
2Ascorbic acid6 h25.47
12 h28.03
24 h21.74
3R. apiculata extract6 h11.63
12 h14.58
24 h18.74
4AgNPs6 h14.43
12 h20.56
24 h18.23
Table
Table 10. Percentage of wound closure of different test samples.
Table 10. Percentage of wound closure of different test samples.
Sl.NoTest SamplePercentage of Wound Closure at 24 h
1Untreated9.13
2Standard drug Ascorbic acid96.26
3R. apiculata extract 75.23
4AgNPs82.79
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Alsareii, S.A.; Manaa Alamri, A.; AlAsmari, M.Y.; Bawahab, M.A.; Mahnashi, M.H.; Shaikh, I.A.; Shettar, A.K.; Hoskeri, J.H.; Kumbar, V. Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity. Molecules 2022, 27, 6306. https://doi.org/10.3390/molecules27196306

AMA Style

Alsareii SA, Manaa Alamri A, AlAsmari MY, Bawahab MA, Mahnashi MH, Shaikh IA, Shettar AK, Hoskeri JH, Kumbar V. Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity. Molecules. 2022; 27(19):6306. https://doi.org/10.3390/molecules27196306

Chicago/Turabian Style

Alsareii, Saeed Ali, Abdulrahman Manaa Alamri, Mansour Yousef AlAsmari, Mohammed A. Bawahab, Mater H. Mahnashi, Ibrahim Ahmed Shaikh, Arun K. Shettar, Joy H. Hoskeri, and Vijay Kumbar. 2022. "Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity" Molecules 27, no. 19: 6306. https://doi.org/10.3390/molecules27196306

Article Metrics

Back to TopTop